HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$7.68
Day range
$7.70 - $8.48
Year range
$6.15 - $987.02
Market cap
6.84M USD
Avg Volume
65.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.17M | -3.58% |
Net income | -12.09M | -263.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.16M | 3.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.57M | 135.45% |
Total assets | 13.19M | 80.98% |
Total liabilities | 2.90M | 7.22% |
Total equity | 10.29M | — |
Shares outstanding | 833.62K | — |
Price to book | 0.62 | — |
Return on assets | -77.39% | — |
Return on capital | -190.75% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -12.09M | -263.27% |
Cash from operations | -3.10M | 21.35% |
Cash from investing | — | — |
Cash from financing | 8.85M | 45.47% |
Net change in cash | 5.76M | 168.31% |
Free cash flow | -2.19M | 14.61% |
About
Founded
2016
Headquarters
Website
Employees
7
